Financial Liabilities

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Financial Liabilities

7. Financial Liabilities

The Company’s financial liabilities consist of (in thousands):

	March 31,			December 31,
	2023			2022
Revolving loan facility	$	10,000		$	—
Less: Unamortized debt issuance costs		(59	)		—
Financial liabilities, net of debt issuance costs	$	9,941		$	—

On February 8, 2017, the Company entered into a Loan and Security Agreement (as amended or amended and restated from time to time, the “Loan Agreement”) with East West Bank (“EWB”). Following subsequent amendments, on April 14, 2022, the Company and EWB amended the Loan Agreement replacing the $20.0 million revolving loan facility subject to a borrowing base with a non-formula revolving loan facility with no borrowing base requirement and a maturity date of February 8, 2023. In addition, the interest rate was lowered from prime to prime minus 0.25% (interest rate as of March 31, 2023 was 7.75%), and certain financial covenants were amended. On February 8, 2023, the Company entered into an amendment (the "Fourth Amendment") to the Loan Agreement. The Fourth Amendment amends the Loan Agreement to, among other things, extend the maturity date to February 8, 2025, and amend certain financial covenants.

The Loan Agreement contains customary representations and warranties and customary affirmative and negative covenants, including, limits or restrictions on the Company’s ability to incur liens, incur indebtedness, make certain restricted payments (including dividends), merge or consolidate and dispose of assets, as well as other financial covenants. The Company’s obligations under the Loan Agreement are collateralized by substantially all of its assets. As of March 31, 2023, there was $10.0 million outstanding and the Company was in compliance with all financial covenants under the Loan Agreement. On May 4, 2023, the Company repaid $7.0 million of the amounts outstanding under the revolving loan facility.